Table 4.
Reference | Study design | TBI type | Age category | Patients (n) | Antithrombotic treatment (n, %) | Hemostatic comorbidities | Sampling times | First sample | Results |
---|---|---|---|---|---|---|---|---|---|
Grenander [21] | RCT | Isolated TBI | Adults | 28 | 0 (0%) | Excluded those with known bleeding or coagulation disorders | On admission and 8, 16, 24, 36, 48, 72, 96, 120 h after injury | Mean 8.6 h after injury | Elevated TAT on admission that then decreased and reached reference levels 5 days after injury |
Nekludov [41] | Prospective observational | Isolated severe TBI | Adults | 11 | 0 (0%) | Excluded those with known coagulation disorders or alcohol abuse | On admission and 3 days after injury | 15.4 ± 2.6 h after injury | Elevated TAT and F1 + 2 on admission that decreased and reached reference levels 24 h after injury |
Sørensen [42] | Prospective observational | Isolated severe TBI | All ages | 14 | N/A | N/A | On admission and 1, 2, 3, 7 days after injury | N/A | Elevated TAT and F1 + 2 on admission that then decreased but remained elevated during time studied |
Gando [43] | Prospective observational | Isolated TBI | Adults | 5 | 0 (0%) | Excluded those with preexisting coagulation disorders | On admission and 1, 2, 3, 4 days after injury | N/A | Elevated TAT and F1 + 2 on admission that then decreased but remained elevated during time studied |
Scherer [34] | Prospective observational | Isolated severe TBI | Adults | 20 | N/A | N/A | A and 3 h after admission | N/A | Elevated TAT and F1 + 2 on admission that then decreased but remained elevated during time studied |
F1 + 2 = prothrombin fragment F1 + 2; h hours; TAT thrombin–antithrombin complex; TBI traumatic brain injury